Atlas Trials

Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

Clinical trial NCT02771210 · COMPLETED

Trial details

NCT number
NCT02771210
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriatic ArthritisAxial SpondyloarthritisEnthesitis
Start date
2016-08-30
Primary completion
2019-12-11
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.